mass spectrometry raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-05-29 and is reviewed periodically as new material appears.
Microbial contamination is a concern for aqueous peptide solutions, especially those without preservatives. Bacteriostatic water contains an antimicrobial preservative and is used in some laboratory settings, while sterile water lacks preservatives. Filtration through a sterile filter can reduce particulates and microbes, but some peptides adsorb to filter membranes. The effect of preservatives on peptide stability is peptide-dependent and not fully predictable. Documentation of lot number, solvent, date, and storage conditions supports traceability and reproducibility.
After reconstitution, peptide solutions are generally less stable than lyophilized powders, and hydrolysis, oxidation, deamidation, and aggregation can occur in solution. Stability depends on peptide sequence, concentration, pH, buffer composition, temperature, light exposure, and dissolved oxygen. Many research protocols store reconstituted solutions at 4 °C for short periods or at -20 °C or -80 °C for longer periods. Repeated freeze-thaw cycles can promote aggregation and loss of activity. The optimal storage condition is peptide-specific and often determined empirically rather than predicted from sequence alone.
Quality control after reconstitution often includes visual inspection for particulates, pH measurement, and concentration determination by ultraviolet absorbance at 280 nm when aromatic residues are present. Reverse-phase high-performance liquid chromatography can assess purity and reveal degradation peaks. Mass spectrometry confirms molecular identity and detects modifications such as oxidation or truncation. Size-exclusion chromatography can quantify aggregates and oligomers. These methods are established for many peptides but may require optimization for hydrophobic or chemically modified sequences.
Quality records typically include a certificate of analysis, batch number, molecular weight, purity result, and recommended storage conditions. After reconstitution, a laboratory log may record solvent, final volume, date, and storage location. Such documentation supports reproducibility and allows later investigation if a preparation behaves unexpectedly. Stability studies often examine purity and concentration over time under defined temperatures, but results are not universally transferable between peptides or formulations. Open questions remain about how best to predict aggregation for specific sequences and how much analytical testing is sufficient for routine laboratory work.
After a peptide is reconstituted, analytical checks can confirm identity, concentration, and purity. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry provides a mass value that supports sequence identity, while ultraviolet absorbance at 214 or 280 nanometers is often used for concentration estimation when the extinction coefficient is known. These methods answer different questions and are complementary. A single measurement rarely establishes full quality, because the same sample can appear acceptable by one method and fail another.
| Property | Value | Notes |
|---|---|---|
| Typical storage after reconstitution | 2 to 8 °C for short term | Frozen storage at -20 °C or below is used for longer intervals. |
| Freeze-thaw stability | Peptide-dependent | Repeated cycles may increase aggregation and loss. |
| Common preservative | Benzyl alcohol | Found in bacteriostatic water; compatibility varies by peptide. |
| Purity method | Reverse-phase HPLC | Detects degradation products and related impurities. |
| Identity method | Mass spectrometry | Confirms molecular mass and modification state. |
Container selection matters because peptides can adsorb to glass, plastic, and filter membranes. Low-binding polypropylene tubes reduce losses for hydrophobic sequences, and filtration through a 0.22 µm membrane can remove particulates and microorganisms. Some peptides may bind to certain filter materials, so compatibility should be checked. Aliquots should be prepared before freezing to avoid repeated temperature cycling. Labels should record the peptide identity, lot number, solvent, concentration, reconstitution date, and storage condition.
After reconstitution, the peptide solution is less stable than the dried powder because water enables hydrolysis, oxidation, and microbial growth. Storage temperature, pH, buffer composition, and container material all affect how long the solution remains usable. Many peptides are kept at 2–8 °C for short-term work, while frozen aliquots at −20 °C or below are used for longer intervals. Repeated freeze-thaw cycles can cause aggregation or precipitation. The choice of storage condition should be based on stability data for the specific peptide.
Quality checks after reconstitution include visual inspection, pH measurement, and analytical methods such as reversed-phase high-performance liquid chromatography. These tests can detect insoluble material, degradation products, and changes in concentration. Mass spectrometry is often used to confirm molecular identity when the peptide sequence is known. Because a clear solution can still contain aggregates or modified peptide, visual clarity alone is not sufficient. Analytical results are compared with a reference standard or the pre-reconstitution certificate of analysis.
Aseptic technique is used when a reconstituted solution must remain free of microbial contamination. Work surfaces, gloves, and instruments are cleaned, and the septum of a vial is disinfected before solvent is added. A venting needle or pressure equalization can prevent aerosol formation and pressure buildup. Bacteriostatic water contains an antimicrobial preservative, but preservatives can interfere with some assays or alter peptide behavior. Sterile filtration may be used when a formulation cannot be heat sterilized or when particulates must be removed.
Quality control for reconstituted peptides includes recording lot number, solvent, date, and storage conditions. Visual inspection checks clarity, color, and particles, while pH measurement verifies the expected solution environment. Concentration is often estimated by ultraviolet absorbance at 280 nm for peptides containing tryptophan or tyrosine, or by high-performance liquid chromatography. Mass spectrometry can confirm molecular identity before reconstitution. Sterility testing is relevant when microbial contamination would invalidate an experiment, though such testing is not routinely performed in every laboratory.
Once a peptide is dissolved, water becomes a medium for hydrolysis, oxidation, and deamidation. Dry powders often tolerate ambient shipping better than liquid solutions, but the exact stability profile depends on sequence and formulation. Refrigerated storage near 2 to 8 degrees Celsius or frozen storage at minus 20 or minus 80 degrees Celsius is common in laboratories. Repeated freeze-thaw cycles can promote aggregation, precipitation, or loss of activity. Dividing a solution into single-use aliquots before freezing can reduce the number of temperature cycles.
Biomass is a form of renewable energy useful as fuel and as a source of some chemical products. Relative to coal and petroleum however, the energy content of biomass is low. Compared to traditional fossil fuels, biomass has a high oxygen content. Its carbon is partially combusted, so to speak. One such notable example is the production of bio-ethanol. There is a general classification of biomass that is produced or sourced for conversion processes. Biofuels such as bioethanol and biodiesel, and bioplastics, are typically derived from primary or “first-generation” source energy-dense plants and oils such as rapeseed, sugarcane, or corn. Their high content of sugars and oils makes them ideal as feedstocks, however, there are drawbacks to their use. As well as inflating the price of the chosen crop due to increased demand, arable land that would otherwise be used to grow food for human and animal consumption is rendered unavailable. Secondary or “second-generation” source biomass encompasses a much wider variety of plant and animal matter. It may be derived from a relatively pure source, such as wood chippings or grass, or it may be a less well defined solid waste stream. This type of biomass is far more challenging to work with, as it contains a more varied mixture of compounds that cannot be easily converted into useful products.
=== Creatinine clearance CCr === One method of determining GFR from creatinine is to collect urine (usually for 24 h) to determine the amount of creatinine that was removed from the blood over a given time interval. If one removes 1440 mg in 24 h, this is equivalent to removing 1 mg/min. If the blood concentration is 0.01 mg/mL (1 mg/dL), then one can say that 100 mL/min of blood is being "cleared" of creatinine, since, to get 1 mg of creatinine, 100 mL of blood containing 0.01 mg/mL would need to have been cleared. Creatinine clearance (CCr) is calculated from the creatinine concentration in the collected urine sample (UCr), urine flow rate (Vdt), and the plasma concentration (PCr). Since the product of urine concentration and urine flow rate yields creatinine excretion rate, which is the rate of removal from the blood, creatinine clearance is calculated as removal rate per min (UCr×Vdt) divided by the plasma creatinine concentration. This is commonly represented mathematically as
=== Etymology === Phenyl is derived from French phényle, which in turn derived from Greek φαίνω (phaino) 'shining', as the first phenyl compounds named were byproducts of making and refining various gases used for lighting. According to McMurry, "The word is derived from Greek pheno 'I bear light', commemorating the discovery of benzene by Michael Faraday in 1825 from the oily residue left by the illuminating gas used in London street lamps."
Shankersinh Vaghela (born 21 July 1940) is an Indian politician and former Chief Minister of Gujarat. He was also the Leader of Opposition in 13th Gujarat Legislative Assembly. Vagela started his political career with the Jana Sangh, which later merged into the Janata Party in 1977. After Janata Party split into various fractions, Vaghela became a senior leader of the Bharatiya Janata Party (BJP). In 1996, he broke away from the BJP and formed the Rashtriya Janata Party. He served as the Chief Minister of Gujarat from 1996 to 1997. Later, his party merged with Indian National Congress (Congress). On 21 July 2017, he left Congress and resigned from the post of the leader of opposition. He formed new outfit Jan Vikalp Morcha which contested but did not win any of the seats in 2017 Gujarat Legislative Assembly election. He was a member of the Nationalist Congress Party in 2019-20. He has also served as a Member of Parliament, having been elected to the 6th, 9th (1989-1991), 10th, 13th and 14th Lok Sabhas. He was also a member of the Rajya Sabha from 1984 to 1989. He served as the Union Cabinet Minister of Textiles from 2004 to 2009 in the First Manmohan Singh Cabinet. He represented the Kapadvanj constituency in the Gujarat legislative assembly from 2012 to 2017.
An exclusive license outside of South Korea and China with Sanofi for Hanmi's Glucagon-like peptide-1 receptor agonist drug candidates for diabetes; Sanofi paid $434 million upfront and up to $3.2 billion in milestones and royalties over 10%. The deal included efpeglenatide, a long-acting glucagon-like peptide-1 receptor agonist; an insulin intended to be delivered once per week, and a fixed-dosed weekly GLP1-RA/insulin drug combination. An exclusive license outside of South Korea and China with the J&J subsidiary Janssen Pharmaceuticals for Hanmi's oxyntomodulin-analog metabolic disease programs, including HM12525A; J&J paid $105 million upfront and the deal included $810M in milestones and royalties higher than 10% An exclusive license in China with the Chinese company ZAI Labs for olmutinib. In April 2016 Hanmi announced that it had acquired land near Yantai in the Shandong province of China, where it would build a manufacturing plant and R&D facility; at that time it already had a facility in Beijing. In July Hanmi said it intended to invest more heavily in developing candidate substances of promising new drugs at an early stage in new pharmaceutical and biotech related fields, including through a venture capital firm set up by Sung-ki and colleagues. In May 2016 the Korean regulatory authority approved olmutinib as a second-line treatment for certain kinds of non-small cell lung cancer.
Sources: en.wikipedia.org
Smoking tobacco has serious negative effects on human health. Tobacco smoking is the greatest cause of preventable death globally. Half of tobacco smokers die from complications related to smoking. Active smokers are estimated to die an average of 10 years earlier than non-smokers. The World Health Organization estimates that, annually, more than 7 million people die from tobacco-related causes, including 1.6 million non-smokers due to passive smoking. It is further estimated to have caused 100 million deaths in the 20th century. Tobacco smoke contains over 70 chemicals, known as carcinogens, that cause cancer. It also contains nicotine, a highly addictive psychoactive drug. When tobacco is smoked, the nicotine causes physical and psychological dependency. Cigarettes sold in least developed countries have higher tar content and are less likely to be filtered, increasing vulnerability to tobacco smoking–related diseases in these regions. Tobacco use most commonly leads to diseases affecting the heart, liver, and lungs. Smoking is a major risk factor for several conditions, namely pneumonia, heart attacks, strokes, chronic obstructive pulmonary disease (COPD)—including emphysema and chronic bronchitis—and multiple cancers (particularly lung cancer, cancers of the larynx and mouth, bladder cancer, and pancreatic cancer). It is also responsible for peripheral arterial disease and high blood pressure. The effects vary depending on how frequently and for how many years a person smokes.
=== Supplements === α-KIC has been studied as a nutritional supplement to aid in the performance of strenuous physical activity. Studies have shown that taking ɑ-KIC and its derivatives before acute physical activity led to an increase in muscle work by 10%, as well as a decrease in muscle fatigue during the early phase of the physical activity. When taken with other supplements over a two-week period, such as beta-hydroxy beta-methylbutyrate (HMB), participants reported delayed onset of muscle soreness, as well as other positive effects such as increased muscle girth. Studies have also suggested that ɑ-KIC taken alone did not have any significant positive impacts on physical performance, so it should be taken in conjunction with other ergogenic substances. ɑ-KIC is not available as a supplement on its own, but its decarboxylated form HMB is available in calcium salt capsules or powder.
Agilent ChemStation is a software package to control Agilent liquid chromatography, gas chromatography, and ultraviolet-visible spectroscopy systems such as the 1050, 1100 and 1200 Series HPLC system and the 8453 and 8454 single-beam diode array detector spectrophotometers. It is an evolution of the Hewlett-Packard ChemStation System. Two versions are available: one ("online") in connection with the modules of the HPLC chain is designed to control instruments and run experiments, and the other ("offline"), without a connection with the HPLC chain, is designed to analyze data. ChemStation is structured around a number of registers. Two of the more important registers are CHROMREG and CHROMRES, the chromatographic data registers. Other special registers exist for the UV-vis implementation of the software. ChemStation has a command line interpreter and can run macros. Those macros are files grouping a set of commands. These files possess a .mac extension. ChemStation can import analysis lists and export result files in XML by adding new lines to the ChemStation.ini configuration file. This is a feature to implement the connection with a Laboratory information management system (LIMS).
The frequency of occurrence of a hormonally dependent behavior should correspond to that of its hormonal source. A hormonally dependent behavior is not expected if the hormonal source (or its types of action) is non-existent. The reintroduction of a missing behaviorally dependent hormonal source (or its types of action) is expected to bring back the absent behavior.
Citing the Shafer report, a lobbying campaign from 1973 to 1978, spearheaded by the National Organization for the Reform of Marijuana Laws (NORML), convinced 11 states to decriminalize cannabis for personal use. In 1973, Nixon created the Drug Enforcement Administration (DEA) by an executive order accepted by Congress, to "establish a single unified command to combat an all-out global war on the drug menace." The agency was charged with enforcing US controlled substances laws and regulations nationally and internationally, coordinating with federal, state and local agencies and foreign governments, and overseeing legally produced controlled substances. The DEA absorbed the Bureau of Narcotics and Dangerous Drugs, ODALE, and other drug-related federal agencies or personnel from them.
Sources: en.wikipedia.org
There is no universal duration because stability varies widely by peptide. Short-term storage at refrigerated temperatures and longer-term storage at frozen temperatures are common in research settings. Degradation markers should be checked periodically.
Cloudiness can result from incomplete dissolution, aggregation, or precipitation of a hydrophobic peptide. It may also indicate contamination or an incompatible solvent. Centrifugation or filtration can sometimes clarify the solution, but the underlying cause should be identified.
Mass spectrometry verifies that the dissolved peptide has the expected molecular mass. It can detect oxidation, truncation, or other modifications that change mass. This check complements chromatographic purity data.
Ultraviolet absorbance is common when the peptide's extinction coefficient is known. Reverse-phase HPLC with calibration standards can also estimate concentration. Amino acid analysis or quantitative mass spectrometry may be used when higher accuracy is needed.